Clinical Trial: Perioperative Adebrelimab in Resectable Stage II–IIIb Non-Small Cell Lung Cancer: A Prospective, Multicenter, Non-Interventional Real-World Study (China)

Posted On: 2026-11-04

China, Nov. 4 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Perioperative Adebrelimab in Resectable Stage II–IIIb Non-Small Cell Lung Cancer: A Prospective, Multicenter, Non-Interventional Real-World Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135834

Registration Time: 2026/11/03

Type: Observational study

Primary Sponsor: Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=348031

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Perioperative Adebrelimab in Resectable Stage II–IIIb Non-Small Cell Lung Cancer: A Prospective, Multicenter, Non-Interventional Real-World Study (China)